Exact Sciences Stock Analysis
| EXAS Stock | USD 103.43 0.14 0.14% |
IPO Date 1st of February 2001 | 200 Day MA 68.4139 | 50 Day MA 102.058 | Beta 1.422 |
EXACT Sciences holds a debt-to-equity ratio of 0.765. Net Debt is likely to gain to about 1.6 B in 2026. Short and Long Term Debt Total is likely to gain to about 2.6 B in 2026 EXACT Sciences' financial risk is the risk to EXACT Sciences stockholders that is caused by an increase in debt.
Asset vs Debt
Equity vs Debt
EXACT Sciences' liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. EXACT Sciences' cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the Company is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps EXACT Stock's retail investors understand whether an upcoming fall or rise in the market will negatively affect EXACT Sciences' stakeholders.
For many companies, including EXACT Sciences, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for EXACT Sciences, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, EXACT Sciences' management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Price Book 7.8391 | Enterprise Value Ebitda 215.112 | Price Sales 6.0806 | Shares Float 189.1 M | Wall Street Target Price 105.8125 |
EXACT Sciences is overvalued with Real Value of 95.57 and Target Price of 105.81. The main objective of EXACT Sciences stock analysis is to determine its intrinsic value, which is an estimate of what EXACT Sciences is worth, separate from its market price. There are two main types of EXACT Sciences' stock analysis: fundamental analysis and technical analysis.
The EXACT Sciences stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. EXACT Sciences is usually not traded on Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day ( substitute day ), Independence Day. EXACT Stock trading window is adjusted to America/New York timezone.
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in EXACT Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. EXACT Stock Analysis Notes
About 87.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 1.09. EXACT Sciences had not issued any dividends in recent years. Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin. Exact Sciences operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 6420 people. To learn more about EXACT Sciences call Kevin Conroy at 608 284 5700 or check out https://www.exactsciences.com.EXACT Sciences Investment Alerts
| The company reported the previous year's revenue of 3.25 B. Net Loss for the year was (207.95 M) with profit before overhead, payroll, taxes, and interest of 2.26 B. | |
| EXACT Sciences has a poor financial position based on the latest SEC disclosures | |
| Over 87.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from finance.yahoo.com: Exact Sciences Stockholders Approve Acquisition by Abbott |
EXACT Largest EPS Surprises
Earnings surprises can significantly impact EXACT Sciences' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2010-10-27 | 2010-09-30 | -0.07 | -0.08 | -0.01 | 14 | ||
2014-02-20 | 2013-12-31 | -0.19 | -0.17 | 0.02 | 10 | ||
2013-10-29 | 2013-09-30 | -0.18 | -0.16 | 0.02 | 11 |
EXACT Sciences Environmental, Social, and Governance (ESG) Scores
EXACT Sciences' ESG score is a quantitative measure that evaluates EXACT Sciences' performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of EXACT Sciences' operations that may have significant financial implications and affect EXACT Sciences' stock price as well as guide investors towards more socially responsible investments.
EXACT Stock Institutional Investors
Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Ameriprise Financial Inc | 2025-06-30 | 2.2 M | Goldman Sachs Group Inc | 2025-06-30 | 2.2 M | Millennium Management Llc | 2025-06-30 | 2.2 M | Holocene Advisors, Lp | 2025-06-30 | 2.1 M | William Blair Investment Management, Llc | 2025-06-30 | 2 M | Dimensional Fund Advisors, Inc. | 2025-06-30 | 1.9 M | Ubs Asset Mgmt Americas Inc | 2025-06-30 | 1.9 M | Bamco Inc | 2025-06-30 | 1.9 M | Aqr Capital Management Llc | 2025-06-30 | 1.8 M | Fmr Inc | 2025-06-30 | 26.9 M | Capital World Investors | 2025-06-30 | 18.2 M |
EXACT Market Capitalization
The company currently falls under 'Large-Cap' category with a current market capitalization of 19.74 B.EXACT Profitablity
The company has Profit Margin (PM) of (0.06) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.09) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.09.| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.08) | (0.08) | |
| Return On Capital Employed | (0.02) | (0.02) | |
| Return On Assets | (0.04) | (0.04) | |
| Return On Equity | (0.09) | (0.09) |
Management Efficiency
EXACT Sciences has return on total asset (ROA) of (0.0159) % which means that it has lost $0.0159 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0866) %, meaning that it created substantial loss on money invested by shareholders. EXACT Sciences' management efficiency ratios could be used to measure how well EXACT Sciences manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.08 in 2026. Return On Capital Employed is likely to drop to -0.02 in 2026. At this time, EXACT Sciences' Intangibles To Total Assets are comparatively stable compared to the past year. Debt To Assets is likely to gain to 0.45 in 2026, whereas Return On Tangible Assets are likely to drop (0.08) in 2026.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 12.72 | 13.36 | |
| Tangible Book Value Per Share | (4.70) | (4.47) | |
| Enterprise Value Over EBITDA | 169.22 | 177.68 | |
| Price Book Value Ratio | 7.98 | 4.65 | |
| Enterprise Value Multiple | 169.22 | 177.68 | |
| Price Fair Value | 7.98 | 4.65 | |
| Enterprise Value | 352.5 M | 370.1 M |
Evaluating the management effectiveness of EXACT Sciences allows investors to assess its financial health and operational efficiency. Coupled with an analysis of its growth prospects and the current market dynamics, we evaluate the stock's true value and future potential. Key indicators such as revenue, earnings or debt levels are examined alongside external factors like economic trends and regulatory changes. The EXACT Stock analysis seeks to determine whether the stock is undervalued, appropriately priced, or overvalued, thereby guiding your investment decisions.
Technical Drivers
As of the 21st of February, EXACT Sciences owns the Market Risk Adjusted Performance of (1.57), coefficient of variation of 498.91, and Standard Deviation of 3.56. EXACT Sciences technical analysis allows you to utilize past data patterns in order to determine a pattern that computes the direction of the firm's future prices. Please confirm EXACT Sciences standard deviation, as well as the relationship between the maximum drawdown and expected short fall to decide if EXACT Sciences is priced correctly, providing market reflects its prevailing price of 103.43 per share. Given that EXACT Sciences has treynor ratio of (1.58), we urge you to verify EXACT Sciences's latest market performance to make sure the company can sustain itself in the future.EXACT Sciences Price Movement Analysis
The output start index for this execution was nine with a total number of output elements of fifty-two. The Simple Moving Average indicator is calculated by adding the closing price of EXACT Sciences for a given number of time periods and then dividing this total by the number of time periods. It is used to smooth out EXACT Sciences short-term fluctuations and highlight longer-term trends or cycles.
EXACT Sciences Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific EXACT Sciences insiders, such as employees or executives, is commonly permitted as long as it does not rely on EXACT Sciences' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases EXACT Sciences insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
EXACT Sciences Outstanding Bonds
EXACT Sciences issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. EXACT Sciences uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most EXACT bonds can be classified according to their maturity, which is the date when EXACT Sciences has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
EXACT Sciences Predictive Daily Indicators
EXACT Sciences intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of EXACT Sciences stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
EXACT Sciences Corporate Filings
8K | 20th of February 2026 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
| 17th of February 2026 Other Reports | ViewVerify | |
8K | 13th of February 2026 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
8K | 10th of February 2026 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
| 30th of January 2026 Other Reports | ViewVerify | |
| 23rd of January 2026 Other Reports | ViewVerify | |
13A | 16th of January 2026 An amended filing to the original Schedule 13G | ViewVerify |
| 9th of January 2026 Other Reports | ViewVerify |
EXACT Sciences Forecast Models
EXACT Sciences' time-series forecasting models are one of many EXACT Sciences' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary EXACT Sciences' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.EXACT Sciences Bond Ratings
EXACT Sciences financial ratings play a critical role in determining how much EXACT Sciences have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for EXACT Sciences' borrowing costs.| Piotroski F Score | 4 | Poor | View |
| Beneish M Score | (2.86) | Unlikely Manipulator | View |
EXACT Sciences Debt to Cash Allocation
Many companies such as EXACT Sciences, eventually find out that there is only so much market out there to be conquered, and adding the next product or service is only half as profitable per unit as their current endeavors. Eventually, the company will reach a point where cash flows are strong, and extra cash is available but not fully utilized. In this case, the company may start buying back its stock from the public or issue more dividends.
EXACT Sciences currently holds 2.52 B in liabilities with Debt to Equity (D/E) ratio of 0.77, which is about average as compared to similar companies. EXACT Sciences has a current ratio of 2.43, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about EXACT Sciences' use of debt, we should always consider it together with its cash and equity.EXACT Sciences Total Assets Over Time
EXACT Sciences Assets Financed by Debt
The debt-to-assets ratio shows the degree to which EXACT Sciences uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.EXACT Sciences Debt Ratio | 45.0 |
EXACT Sciences Corporate Bonds Issued
EXACT Net Debt
Net Debt |
|
About EXACT Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how EXACT Sciences prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling EXACT shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as EXACT Sciences. By using and applying EXACT Stock analysis, traders can create a robust methodology for identifying EXACT entry and exit points for their positions.
| Last Reported | Projected for Next Year | ||
| Pretax Profit Margin | (0.06) | (0.07) | |
| Operating Profit Margin | (0.03) | (0.03) | |
| Net Loss | (0.06) | (0.07) | |
| Gross Profit Margin | 0.70 | 0.76 |
Current EXACT Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. EXACT analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. EXACT analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
| Target Price | Consensus | # of Analysts | |
| 105.81 | Strong Buy | 26 | Odds |
Most EXACT analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand EXACT stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of EXACT Sciences, talking to its executives and customers, or listening to EXACT conference calls.
EXACT Stock Analysis Indicators
EXACT Sciences stock analysis indicators help investors evaluate how EXACT Sciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading EXACT Sciences shares will generate the highest return on investment. By understating and applying EXACT Sciences stock analysis, traders can identify EXACT Sciences position entry and exit signals to maximize returns.
| Begin Period Cash Flow | 606.6 M | |
| Long Term Debt | 2.3 B | |
| Common Stock Shares Outstanding | 188.7 M | |
| Total Stockholder Equity | 2.4 B | |
| Total Cashflows From Investing Activities | 195.1 M | |
| Tax Provision | 4.1 M | |
| Property Plant And Equipment Net | 831 M | |
| Cash And Short Term Investments | 964.7 M | |
| Cash | 956 M | |
| Accounts Payable | 175.9 M | |
| Net Debt | 1.6 B | |
| 50 Day M A | 102.058 | |
| Total Current Liabilities | 641.2 M | |
| Other Operating Expenses | 3.3 B | |
| Non Current Assets Total | 4.3 B | |
| Forward Price Earnings | 188.6792 | |
| Non Currrent Assets Other | 185.8 M | |
| Stock Based Compensation | 217.7 M |
Additional Tools for EXACT Stock Analysis
When running EXACT Sciences' price analysis, check to measure EXACT Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EXACT Sciences is operating at the current time. Most of EXACT Sciences' value examination focuses on studying past and present price action to predict the probability of EXACT Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EXACT Sciences' price. Additionally, you may evaluate how the addition of EXACT Sciences to your portfolios can decrease your overall portfolio volatility.